Correspondent Anna Zucker reports clinicians are seeing effects from telehealth GLP-1 ads that tie weight to self-worth, though research is still limited.
Recap by typeshit. Full story at BIOENGINEER.
Peptide talk is everywhere from YouTube to Reddit. CNBC looks at what is actually known about their safety.
The post warns that people in their 50s and 60s may blame vision changes on age or screens, when researchers have tied the drug in Ozempic to a rare cause of sudden sight loss.
Facial fat loss during GLP-1 weight loss can mean hollowing, flatter cheeks and looser skin, and Dr. Makkani says creams won't solve all of it.
Health authorities are warning people off unregulated peptides as emergency departments report a rise in severe allergic reactions.
Gallup puts US users near 38 million. Cornell data shows snack spending down 11% early on, while gyms and protein brands chase the new demand.
The Frier Levitt partner warns that drugmakers have deep pockets to pursue sellers, and notes knockoffs of the unapproved drug are already circulating.
Loading…